Search

everythinglearnresearchcommunity

for

Search:↓

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Excess sebum reduces the effectiveness of nanosystems for treating hair follicle conditions.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Skin and hair-picking disorders are common and need both skin and mental health treatments.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

EGFR inhibitors can cause yellowish skin eruptions.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

The pandemic changed how often certain skin conditions were diagnosed.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

PRP shows promise for skin rejuvenation but needs more research.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.